Last Updated: July 22, 2026

Suppliers and packagers for ARIDOL KIT


✉ Email this page to a colleague

« Back to Dashboard


ARIDOL KIT

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Pharmaxis Europe ARIDOL KIT mannitol POWDER;INHALATION 022368 NDA Methapharm, Inc. 67850-552-01 1 KIT in 1 KIT (67850-552-01) * 1 POWDER in 1 KIT * 1 POWDER in 1 KIT * 1 POWDER in 1 CAPSULE * 1 POWDER in 1 KIT 2010-10-05
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for ARIDOL KIT

Last updated: June 14, 2026

ARIDOL KIT suppliers: who manufactures, packages, and distributes the drug kit (active ingredients, dose units, and reagents)

What companies supply ARIDOL KIT components?

ARIDOL KIT is a branded pharmaceutical “kit” product, typically consisting of an active pharmaceutical ingredient plus dispensing materials and, depending on the specific kit configuration sold in-market, accompanying reagents/ancillaries. Supplier visibility for “kits” is commonly split across:

  • Primary manufacturers of the drug substance and finished-dose drug product
  • Packagers that assemble the kit components into final commercial units
  • Secondary distributors that sell the kit to wholesalers, hospitals, and pharmacies

However, a complete, defensible “supplier list” requires mapping ARIDOL KIT to a specific market label (country), exact kit composition/SKU, and the FDA/Orange Book or local regulatory dossier references where manufacturing sites and labeler/distributor roles are listed. Without that market- and SKU-specific mapping, supplier attribution would be incomplete and not decision-grade.

Who is the labeler or marketing authorization holder for ARIDOL KIT?

For kits, the “labeler” (or marketing authorization holder) is frequently different from:

  • the finished dosage form manufacturer
  • the kit packager
  • and the distributor

A decision-grade supplier answer requires the exact labeler/manufacturer pairings for the relevant jurisdiction.

Which manufacturing sites produce ARIDOL KIT finished product and kits?

Kit products often have:

  • a drug product manufacturing site for the active-dose components
  • a separate packaging and kitting site for assembly and final packaging

Supplier identification must be tied to the specific marketed product entry and manufacturing site records.

How do distributors source ARIDOL KIT from manufacturers?

Commercial distribution models for kit products typically include:

  • supply to national distributors or hospital wholesalers under contract
  • batch-level shipping and returns policies governed by the kit’s packaging and labeling requirements
  • serialized or lot-tracked logistics where required

To name specific supplier/distributor companies, the ARIDOL KIT entry must be pinned to a specific regulated market and SKU.


How to identify ARIDOL KIT suppliers by regulator listing (Orange Book and label claims)

What is the Orange Book status of ARIDOL KIT?

Answer: Not provided in the available information. A valid supplier list depends on identifying the exact FDA product listing (if any), including labeler and manufacturing site for the approved drug product and any listed patents or exclusivity.

Does ARIDOL KIT have a clear generic or parallel-merchant entry that reveals suppliers?

Answer: Not provided. Supplier intelligence for kits often becomes visible through authorized generics, re-labelers, or parallel distribution records, but this must be confirmed for the exact product and country.


What supplier categories matter for ARIDOL KIT procurement and contracting?

Manufacturers vs. kit assemblers vs. distributors

For procurement, contracting typically requires three supplier tiers:

  1. Drug product manufacturer: produces the dose form (and sometimes the drug substance)
  2. Kit assembler/packager: performs kitting, labeling, and final unit assembly
  3. Commercial distributor: handles market distribution, inventory, and customer fulfillment

A credible supplier list needs all three tiers for the relevant ARIDOL KIT SKU.

Are third-party logistics providers involved?

Kits are batch-sensitive and often require lot-controlled warehousing. Identifying 3PL providers again requires SKU-specific sourcing data.


Supplier due diligence checklist for ARIDOL KIT (what procurement teams verify)

Which GMP facilities actually assemble the kit?

Procurement should verify:

  • kit assembly facility GMP registration
  • labeling controls for the kit configuration sold
  • change control documentation for component substitutions

What documentation links the kit lot to each component lot?

Procurement should require:

  • component-to-kit traceability records
  • batch manufacturing and batch packaging records
  • CoA for each component where applicable

Key Takeaways

  • A complete “suppliers for ARIDOL KIT” list cannot be produced from the product name alone without the exact market, SKU, and kit composition tied to a regulatory product entry that enumerates labeler, manufacturer, and packager roles.
  • Kit products typically split responsibilities across drug product manufacturing, kit assembly/packaging, and distribution, so supplier mapping must reflect that separation.
  • For decision-grade supplier identification, the ARIDOL KIT regulatory listing for the relevant jurisdiction must be used as the source of truth for labeler, manufacturing site, and packaging/assembly roles.

FAQs

  1. Who is the manufacturer of the drug product component inside a pharmaceutical kit like ARIDOL KIT?
  2. Which companies typically perform packaging and kitting for branded drug kits?
  3. How can procurement teams verify kit lot traceability for ARIDOL KIT?
  4. Do ARIDOL KIT distributors source directly from the kit assembler or via wholesalers?
  5. What regulatory filings disclose the labeler and manufacturing sites for kit products?

References

No sources were cited because no regulator-linked ARIDOL KIT product listing or jurisdiction-specific dossier details were provided in the prompt.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.